ORGANOGENESIS HOLDINGS INC. Basic Shares Outstanding (Weighted Average)
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Basic Shares Outstanding (Weighted Average) of 128.67 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 128.67M shares, a 1.44% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 127.80M shares, a 1.19% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 126.92M shares, a 2.12% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 126.88M shares, a 4.29% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 126.74M shares, a 3.75% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 131.67M shares, a 0.34% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 131.23M shares, a 0.89% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 130.07M shares, a 1.36% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 128.67M shares 10-Q · filed 2026-08-06 | 128.24M shares 10-Q · filed 2026-08-06 | 127.80M shares derived: average of 3 quarters · filed 2026-08-06 | 127.57M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 127.80M shares 10-Q · filed 2026-05-07 | 127.36M shares derived: average of 2 quarters · filed 2026-05-07 | 127.20M shares derived: average of 3 quarters · filed 2026-05-07 | 127.11M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 126.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 126.90M shares derived: average of 2 quarters · filed 2026-02-26 | 126.88M shares derived: average of 3 quarters · filed 2026-08-06 | 126.74M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 126.88M shares 10-Q · filed 2025-11-06 | 126.87M shares derived: average of 2 quarters · filed 2026-08-06 | 126.68M shares 10-Q · filed 2025-11-06 | 127.42M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 126.85M shares 10-Q · filed 2026-08-06 | 126.58M shares 10-Q · filed 2026-08-06 | 127.61M shares derived: average of 3 quarters · filed 2026-08-06 | 128.85M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 126.30M shares 10-Q · filed 2026-05-07 | 127.98M shares derived: average of 2 quarters · filed 2026-05-07 | 129.51M shares derived: average of 3 quarters · filed 2026-05-07 | 130.28M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 129.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 131.12M shares derived: average of 2 quarters · filed 2026-02-26 | 131.60M shares derived: average of 3 quarters · filed 2026-02-26 | 131.67M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 132.58M shares 10-Q · filed 2025-11-06 | 132.57M shares derived: average of 2 quarters · filed 2025-11-06 | 132.34M shares 10-Q · filed 2025-11-06 | 132.06M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 132.57M shares 10-Q · filed 2025-08-07 | 132.22M shares 10-Q · filed 2025-08-07 | 131.89M shares derived: average of 3 quarters · filed 2026-02-26 | 131.75M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 131.86M shares 10-Q · filed 2025-05-08 | 131.55M shares derived: average of 2 quarters · filed 2026-02-26 | 131.47M shares derived: average of 3 quarters · filed 2026-02-26 | 131.43M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 131.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 131.27M shares derived: average of 2 quarters · filed 2026-02-26 | 131.28M shares derived: average of 3 quarters · filed 2026-02-26 | 131.23M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 131.31M shares 10-Q · filed 2024-11-12 | 131.30M shares derived: average of 2 quarters · filed 2024-11-12 | 131.23M shares 10-Q · filed 2024-11-12 | 131.15M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 131.29M shares 10-Q · filed 2024-08-08 | 131.19M shares 10-Q · filed 2024-08-08 | 131.10M shares derived: average of 3 quarters · filed 2025-02-27 | 131.05M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 131.08M shares 10-Q · filed 2024-05-09 | 131.01M shares derived: average of 2 quarters · filed 2025-02-27 | 130.97M shares derived: average of 3 quarters · filed 2025-02-27 | 130.64M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 130.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 130.91M shares derived: average of 2 quarters · filed 2025-02-27 | 130.49M shares derived: average of 3 quarters · filed 2025-02-27 | 130.07M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 130.90M shares 10-Q · filed 2023-11-09 | 130.27M shares derived: average of 2 quarters · filed 2023-11-09 | 129.78M shares 10-Q · filed 2023-11-09 | 129.50M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 129.64M shares 10-Q · filed 2023-08-09 | 129.21M shares 10-Q · filed 2023-08-09 | 129.03M shares derived: average of 3 quarters · filed 2024-02-29 | 128.91M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 128.79M shares 10-Q · filed 2023-05-10 | 128.73M shares derived: average of 2 quarters · filed 2024-02-29 | 128.67M shares derived: average of 3 quarters · filed 2024-02-29 | 128.56M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 128.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 128.61M shares derived: average of 2 quarters · filed 2024-02-29 | 128.48M shares derived: average of 3 quarters · filed 2024-02-29 | 128.33M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 128.55M shares 10-Q · filed 2022-11-09 | 128.39M shares derived: average of 2 quarters · filed 2022-11-09 | 128.22M shares 10-Q · filed 2022-11-09 | 125.34M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 128.24M shares 10-Q · filed 2022-08-09 | 128.05M shares 10-Q · filed 2022-08-09 | 124.27M shares derived: average of 3 quarters · filed 2023-03-01 | 119.46M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 127.87M shares 10-Q · filed 2022-05-10 | 122.29M shares derived: average of 2 quarters · filed 2023-03-01 | 116.54M shares derived: average of 3 quarters · filed 2023-03-01 | 113.58M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 116.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 110.87M shares derived: average of 2 quarters · filed 2023-03-01 | 108.82M shares derived: average of 3 quarters · filed 2023-03-01 | 107.74M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 105.04M shares 10-Q · filed 2021-11-09 | 104.88M shares derived: average of 2 quarters · filed 2021-11-09 | 104.75M shares 10-Q · filed 2021-11-09 | 103.01M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 104.71M shares 10-Q · filed 2021-08-09 | 104.60M shares 10-Q · filed 2021-08-09 | 102.34M shares derived: average of 3 quarters · filed 2022-03-01 | 99.82M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 104.49M shares 10-Q · filed 2021-05-11 | 101.15M shares derived: average of 2 quarters · filed 2022-03-01 | 98.19M shares derived: average of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | 97.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 95.05M shares derived: average of 2 quarters · filed 2022-03-01 | 92.84M shares 10-K · filed 2022-03-01 | |
| 2019-09-30 | 92.28M shares 10-Q · filed 2020-11-09 | 91.18M shares 10-Q · filed 2020-11-09 | ||
| 2018-12-31 | 69.32M shares 10-K · filed 2021-03-16 | |||
| 2017-12-31 | 64.12M shares 10-K · filed 2019-03-18 | 64.08M shares derived: average of 2 quarters · filed 2019-03-18 | 64.06M shares derived: average of 3 quarters · filed 2019-03-18 | 63.87M shares derived: average of 4 quarters · filed 2019-03-18 |
| 2017-09-30 | 64.04M shares 10-K · filed 2019-03-18 | 64.03M shares derived: average of 2 quarters · filed 2019-03-18 | 63.79M shares derived: average of 3 quarters · filed 2019-03-18 | |
| 2017-06-30 | 64.02M shares 10-K · filed 2019-03-18 | 63.67M shares derived: average of 2 quarters · filed 2019-03-18 | ||
| 2017-03-31 | 63.31M shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |